Chain Drug Review - Withdrawal of Crestor urged
The Health Research Group charges that Crestor, a recently approved cholesterol-lowering drug, holds more potential harmful side effects than similar medications. But the FDA and manufacturer AstraZeneca PLC assert that the risk-to-benefit equation in Crestor is similar to that of the other drugs.
Related Results
Crestor concernsFDA rejects Crestor petitionFurther dampener for CrestorCrestor lures consumers with couponsSafety concerns over Crestor
COPYRIGHT 2004 Racher Press, Inc.
COPYRIGHT 2008 Gale, Cengage Learning
